Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly — Stella

Home/Delirium, Postoperative/

View on ClinicalTrials.gov

Recruiting

Back to Delirium, Postoperative trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Korea

Samsung Medical Center, Seoul

Key details

Sponsor

Samsung Medical Center

Enrollment target

~108 participants

Started

October 2023

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

65 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.